CFTC Whistleblower Award for Benchmark Rate Manipulation by Global Banks

CFTC Whistleblower Program award of nearly $200 million in connection with recoveries from global banks that manipulated benchmark rates.

Egon Zehnder Tax Whistleblower Case

State of NY ex rel. American Advisory Services LLC v. Egon Zehnder International, Inc., No. 100115/2017. Filed on January 30, 2017, unsealed on July 21, 2021.

Sandell Hedge Fund Tax Whistleblower Settlement

State of NY ex rel. Tooley, LLC v. Sandell, et al., No. 101494/2018. Whistleblower client received award of 21% of $105 million recovery.

FPR Specialty Pharmacy

United States ex rel. Doe v. FPR Specialty Pharmacy LLC, No. 16-cv-5204 (SDNY). Whistleblower client received 21% of $426,000 ability to pay settlement

Moody’s Corporation Whistleblower Settlement

Anonymous v. Anonymous, No. 103997/2012 (N.Y. Sup. Ct. 2019). Whistleblower client received award of 30% of $8.5 million recovery.

JPMorgan Chase Escheatment

New York ex rel. Raw Data Analytics v. JPMorgan Chase & Co., No. 100271/2015 (N.Y. Sup. Ct.). Defeated defendants' summary judgment motion, and case continues.

Spa Castle Whistleblower Settlement

State of New York ex rel. Choe v. Spa Castle, Inc., No. 101243/2014 (N.Y. Sup. Ct. 2018). Whistleblower client received award of 23% of $2.5 million recovery.

Winds Enterprises Whistleblower Settlement

U.S. ex rel. Dickhudt v. Winds Enterprises, No. 13-cv-01142 (W.D. Wa.). Whistleblower client received award of 20% of $1.5 million settlement.

Noble Jewelry Whistleblower Settlement

U.S. ex rel. Karlin v. Noble Jewelry Co., No. 08-cv-07826 (S.D.N.Y.). Whistleblower client received award of 19% of $3.85 million settlement.

Multi-Defendant Prescription Drug Pricing Settlement

In re Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456 (D. Mass.); City of New York, et al. v. Abbott Laboratories, et al., No. 01-cv-12257 (D. Mass). Represented New York City in False Claims Act case against several prescription drug manufacturers for manipulating Average Wholesale Prices of their drugs, settling for $225 million.